Histopathologic indicators of recurrence in meningiomas: Correlation with clinical and genetic parameters

Virchows Archiv

Volumn 449, Issue 5, 2006, Pages 529-538

  Kim, Yoo Jin ^a   Ketter, Ralf ^a   Henn, Wolfram ^a   Zang, Klaus D ^a   Steudel, Wolf Ingo ^a   Feiden, Wolfgang ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Alkaline phosphatase; Cytogenetics; Ki 67; Meningioma recurrence; Prognosis

Indexed keywords

ALKALINE PHOSPHATASE; KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER SCREENING; CANCER SURVIVAL; CELL LABELING; CHROMOSOME 1P; CHROMOSOME ANALYSIS; CHROMOSOME ARM; CONTROLLED STUDY; COURSE EVALUATION; DISEASE FREE SURVIVAL; ENZYME ACTIVITY; FEMALE; FOLLOW UP; GENETIC CORRELATION; HAZARD ASSESSMENT; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; MORPHOMETRICS; MULTIVARIATE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECURRENT CANCER; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; COHORT STUDIES; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 33750864928     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-006-0285-3     Document Type: Article

References (33)

1. Abramovich CM, Prayson RA (1999) Histopathologic features and MIB-1 labeling indices in recurrent and nonrecurrent meningiomas. Arch Pathol Lab Med 123:793-800
2. Al-Mefty O, Kadri PA, Pravdenkova S, Sawyer JR, Stangeby C, Husain M (2004) Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings. J Neurosurg 101:210-218
3. Bello MJ, de Campos JM, Vaquero J, Kusak ME, Sarasa JL, Rey JA (2000) High-resolution analysis of chromosome 1p alterations in meningioma. Cancer Genet Cytogenet 120:30-36
4. Bouvier C, Liprandi A, Colin C, Giorgi R, Quilichini B, Metellus P, Figarella-Branger D (2005) Lack of alkaline phosphatase activity predicts meningioma recurrence. Am J Clin Pathol 124:252-258
5. Burger PC, Scheithauer BW, Vogel FS (eds) (2002) Surgical pathology of the nervous system and its coverings. Churchill Livingstone, New York
6. Cai DX, Banerjee R, Scheithauer BW, Lohse CM, Kleinschmidt-Demasters BK, Perry A (2001) Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications. J Neuropathol Exp Neurol 60:628-636
7. Ho DM, Hsu CY, Ting LT, Chiang H (2002) Histopathology and MIB-1 labeling index predicted recurrence of meningiomas. A proposal of diagnostic criteria for patients with atypical meningiomas. Cancer 94:1538-1547
8. Jääskeläinen J, Haltia M, Servo A (1986) Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol 25:233-242
9. Kepes JJ (1986) Presidential address: the histopathology of meningiomas. A reflection of origins and expected behavior? J Neuropathol Exp Neurol 45:95-107
10. Ketter R, Henn W, Niedermayer I, Steilen-Gimbel H, Konig J, Zang KD, Steudel WI (2001) Predictive value of progression-associated chromosomal aberrations for the prognosis of meningiomas: a retrospective study of 198 cases. J Neurosurg 95:601-607
11. Kim YJ, Romeike BFM, Uszkoreit J, Feiden W (2006) Automated nuclear segmentation in the determination of the Ki-67 labeling-index in meningiomas. Clin Neuropathol 25:67-73
12. Kolles H, Niedermayer I, Schmitt C, Henn W, Feld R, Steudel WI, Zang KD, Feiden W (1995) Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics. Acta Neurochir (Wien) 137:174-181
13. Limon J, Dal Cin P, Sandberg AA (1986) Application of long-term collagenase disaggregation for the cytogenetic analysis of human solid tumors. Cancer Genet Cytogenet 23: 305-313
14. Kleihues P, Cavenee WK (eds) (2000) Pathology and Genetics, Tumours of the nervous system. IARC Press, Lyon
15. Maier H, Ofner D, Hittmair A, Kitz K, Budka H (1992) Classical, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg 7:616-623
16. McCarthy BJ, Davis FG, Freels S, Surawicz TS, Damek DM, Grutsch J, Menck HR, Laws ER Jr (1998) Factors associated with survival in patients with meningioma. J Neurosurg 88:831-839
17. Murakami M, Hashimoto N, Takahashi Y, Hosokawa Y, Inazawa J, Mineura K (2003) A consistent region of deletion on 1p36 in meningiomas: identification and relation to malignant progression. Cancer Genet Cytogenet 140:99-106
18. Müller P, Henn W, Niedermayer I, Ketter R, Feiden W, Steudel WI, Zang KD, Steilen-Gimbel H (1999) Deletion of chromosome 1p and loss of expression of alkaline phosphatase indicate progression of meningiomas. Clin Cancer Res 5:3569-3577
19. Nakasu S, Li DH, Okabe H, Nakajima M, Matsuda M (2001) Significance of MIB-1 staining indices in meningiomas. Comparison of two counting methods. Am J Surg Pathol 5:472-478
20. Niedermayer I, Feiden W, Henn W, Steilen-Gimbel H, Steudel WI, Zang KD (1997) Loss of alkaline phosphatase activity in meningiomas: a rapid histochemical technique indicating progression-associated deletion of a putative tumor suppressor gene on the distal part of the short arm of chromosome 1. J Neuropathol Exp Neurol 56:879-886
21. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1998) The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer 82:2262-2269
22. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1997) Meningioma grading. An analysis of histological parameters. Am J Surg Pathol 21:1455-1465
23. Prowald A, Ketter R, Zang K, Steudel WI (2003) Two-step inactivation of the tissue non-specific alkaline phosphatase (ALPL) gene during progression of meningiomas by deletion plus promoter methylation. Genes Chromosomes Cancer 9:81
24. Roser F, Samii M, Ostertag H, Bellinzona M (2004) The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases. Acta Neurochir 146:37-44
25. Rosenblum MK, Bilbao JM, Ang LC (2004) Meningiomas. In: Rosai J (ed) Rosai and Ackerman's surgical pathology. Mosby, New York, pp 2564-2572
26. Russell DS, Rubinstein LJ (eds) (1990) Pathology of tumors of the nervous system. Lippincott Williams and Wilkins, Baltimore
27. Simon M, von Deimling A, Larson JJ, Wellenreuther R, Kaskel P, Waha A, Warnick RE, Tew JM Jr, Menon AG (1995) Allelic losses of chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression. Cancer Res 55:4696-4701
28. Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22-39
29. Sulman EP, White PS, Brodeur GM (2004) Genomic annotation of the meningioma tumor suppressor locus on chromosome 1p34. Oncogene 23:1014-1020
30. Torp SH, Lindboe CF, Gronberg BH, Lydersen S, Sundstrom S (2005) Prognostic significance of Ki-67/MIB-1 proliferation index in meningiomas. Clin Neuropathol 24:170-174
31. Zang KD (2001) Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases. Cytogenet Cell Genet 93:207-220
32. Zang KD (1982) Cytological and cytogenetical studies on human meningioma. Cancer Genet Cytogenet 6:249-274
33. Zang KD, Singer H (1967) Chromosomal constitution of meningiomas. Nature 216:84-85